No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr20:1454200-1460800 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
2 |
chr20:1454400-1460400 |
Weak transcription |
Primary hematopoietic stem cells |
blood
|
3 |
chr20:1454400-1460600 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
4 |
chr20:1454400-1460600 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
5 |
chr20:1455600-1461600 |
Enhancers |
Placenta |
Placenta
|
6 |
chr20:1456200-1460400 |
Weak transcription |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
7 |
chr20:1457400-1460800 |
Strong transcription |
Spleen |
Spleen
|
8 |
chr20:1458000-1459400 |
Flanking Active TSS |
HMEC |
breast
|
9 |
chr20:1458200-1459600 |
Strong transcription |
Primary monocytes fromperipheralblood |
blood
|
10 |
chr20:1458400-1459400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
11 |
chr20:1458600-1459400 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
12 |
chr20:1458600-1459400 |
Flanking Active TSS |
NHEK |
skin
|
13 |
chr20:1458800-1460000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
14 |
chr20:1458800-1460000 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
15 |
chr20:1458800-1460400 |
Enhancers |
Hela-S3 |
cervix
|
16 |
chr20:1458800-1460800 |
Strong transcription |
Primary mononuclear cells fromperipheralblood |
Blood
|
17 |
chr20:1459000-1459400 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
18 |
chr20:1459000-1459600 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
19 |
chr20:1459000-1459600 |
Flanking Active TSS |
A549 |
lung
|
20 |
chr20:1459000-1459800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
21 |
chr20:1459000-1459800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
22 |
chr20:1459000-1459800 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
23 |
chr20:1459000-1459800 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
24 |
chr20:1459000-1459800 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
25 |
chr20:1459000-1460000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
26 |
chr20:1459000-1460000 |
Enhancers |
HUVEC |
blood vessel
|
27 |
chr20:1459000-1460000 |
Enhancers |
NH-A |
brain
|
28 |
chr20:1459000-1460000 |
Enhancers |
Osteobl |
bone
|
29 |
chr20:1459000-1460200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
30 |
chr20:1459000-1460200 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
31 |
chr20:1459200-1459600 |
Weak transcription |
Esophagus |
oesophagus
|
32 |
chr20:1459200-1459600 |
Enhancers |
NHLF |
lung
|
33 |
chr20:1459200-1459800 |
Weak transcription |
Lung |
lung
|
34 |
chr20:1459200-1460000 |
Enhancers |
HSMM |
muscle
|
35 |
chr20:1459200-1460400 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
36 |
chr20:1459200-1463600 |
Genic enhancers |
Primary neutrophils fromperipheralblood |
blood
|
37 |
chr20:1459200-1464400 |
Genic enhancers |
Monocytes-CD14+_RO01746 |
blood
|